4884 — Kringle Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Kringle Pharma, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2,103	2,138	2,756	2,136	2,313
Net Total Accounts Receivable
Net Total Receivables	130	83.4	67.9	81.8	57.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,349	2,635	3,208	2,618	2,756
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	0	0	0	0
Other Long Term Assets
Total Assets	2,350	2,636	3,209	2,619	2,757
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	159	127	163	209	128
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	162	129	420	597	649
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,189	2,506	2,789	2,022	2,108
Total Liabilities & Shareholders' Equity	2,350	2,636	3,209	2,619	2,757
Total Common Shares Outstanding